Biotech Values

[DewDiligence]

>MODG has just found a particular CTP that confers stability to proteins, so they'll produce CTP-modified proteins as an alternative to , say, PEGylated proteins.<

What do you see as the pros and cons of the CTP approach relative to the PEGylation approach for producing next-generation versions of protein drugs? Is there enough information in the public domain to speculate? T.i.a. Dew